Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2012 2
2013 1
2014 1
2015 1
2016 1
2018 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators. Fox RJ, et al. N Engl J Med. 2012 Sep 20;367(12):1087-97. doi: 10.1056/NEJMoa1206328. N Engl J Med. 2012. PMID: 22992072 Free article. Clinical Trial.
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators. Gold R, et al. N Engl J Med. 2012 Sep 20;367(12):1098-107. doi: 10.1056/NEJMoa1114287. N Engl J Med. 2012. PMID: 22992073 Free article. Clinical Trial.
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.
Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM; APEX Investigators. Cohen AT, et al. N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27. N Engl J Med. 2016. PMID: 27232649 Free article. Clinical Trial.
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators. Cohen AT, et al. N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096. N Engl J Med. 2013. PMID: 23388003 Free article. Clinical Trial.
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators. Miller DH, et al. Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13. Neurology. 2015. PMID: 25681448 Free PMC article. Clinical Trial.
Viral etiology of acute respiratory infections in hospitalized children in Novosibirsk City, Russia (2013 - 2017).
Kurskaya O, Ryabichenko T, Leonova N, Shi W, Bi H, Sharshov K, Kazachkova E, Sobolev I, Prokopyeva E, Kartseva T, Alekseev A, Shestopalov A. Kurskaya O, et al. Among authors: ryabichenko t. PLoS One. 2018 Sep 18;13(9):e0200117. doi: 10.1371/journal.pone.0200117. eCollection 2018. PLoS One. 2018. PMID: 30226876 Free PMC article. Clinical Trial.
Policy as normative influence? On the relationship between parental leave policy and social norms in gender division of childcare across 48 countries.
Schindler S, Schuster C, Olsson MIT, Froehlich L, Hübner AK, Block K, Van Laar C, Schmader T, Meeussen L, van Grootel S, Croft A, Sun MS, Ainsaar M, Aarntzen L, Adamus M, Anderson J, Atkinson C, Avicenna M, Bąbel P, Barth M, Benson-Greenwald T, Maloku E, Berent J, Bergsieker HB, Biernat M, Birneanu A, Bodinaku B, Bosak J, Bosson J, Branković M, Burkauskas J, Čavojová V, Cheryan S, Choi E, Choi I, Contreras-Ibáñez CC, Coogan A, Danyliuk I, Dar-Nimrod I, Dasgupta N, de Lemus S, Devos T, Diab M, Diekman AB, Efremova M, Eisner L, Eller A, Erentaite R, Fedáková D, Franc R, Gartzia L, Gavreliuc A, Gavreliuc D, Gecaite-Stonciene J, Germano AL, Giovannelli I, Gismondi Diaz R, Gitikhmayeva L, Gizaw AM, Gjoneska B, González OM, González R, Grijalva ID, Güngör D, Gustafsson Sendén M, Hall W, Harb C, Hassan B, Hässler T, Hawi DR, Henningsen L, Hoppe A, Ishii K, Jakšić I, Jasini A, Jurkevičienė J, Kelmendi K, Kirby TA, Kitakaji Y, Kosakowska-Berezecka N, Kozytska I, Kulich C, Kundtová-Klocová E, Kunuroglu F, Aidy CL, Lee A, Lindqvist A, López-López W, Luzvinda L, Maricchiolo F, Martinot D, McNamara RA, Meister A, Melka TL, Mickuviene N, Miranda-Orrego MI, Mkamwa T, Morandini J, Morton T, Mrish… See abstract for full author list ➔ Schindler S, et al. Among authors: ryabichenko t. Br J Soc Psychol. 2024 Oct 23. doi: 10.1111/bjso.12806. Online ahead of print. Br J Soc Psychol. 2024. PMID: 39439425
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group. Confavreux C, et al. Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23. Lancet Neurol. 2014. PMID: 24461574 Clinical Trial.